APOE and Alzheimer disease: To evaluate how well the CSF proteome reflects AD pathology, we trained random forest regression models using MS protein levels following the same configurations described earlier and compared their performance with models based on age, APOE4 status, and conventional CSF biomarkers (Aβ42 and pTau181) (Fig. 7E).